Cyclosporin A withdrawal in live related renal transplantation: Long-term results

Clinical Transplantation

Volumn 15, Issue 2, 2001, Pages 136-141

  Dubey, Deepak ^a   Kumar, Anant ^a,b   Srivastava, Aneesh ^a   Mandhani, Anil ^a   Sharma, Ajay Prakash ^b   Gupta, Amit ^b   Sharma, Rk ^b  

^a Departments of Urology   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cyclosporin A withdrawal; Immunosuppression; Renal transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; OKT 3; PENTETATE TECHNETIUM TC 99M; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CADAVER KIDNEY; CHRONIC DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG COST; DRUG SAFETY; DRUG WITHDRAWAL; ECONOMIC ASPECT; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK; SURVIVAL TIME; TOXICITY;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; RISK FACTORS; TIME FACTORS;

EID: 0035093935     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150210.x     Document Type: Article

References (26)

1. The case for withdrawal of cyclosporin after renal transplantation
2. Cyclosporin withdrawal: To be or not to be!
3. Tapering or discontinuing cyclosporin for financial reasons - A single center experience
4. Chronic cyclosporin nephropathy: The Achilles heel of immunosuppressive therapy
5. Long-term outlook for renal transplant recipients with 1-year function: 'Doctor what are my chances?'
6. Cyclosporin in primary haploidentical live-donor kidney transplantation: Is it worthwhile
7. Conversion from cyclosporin to azathioprine prednisolone
8. Cyclosporin treatment with conversion after 3 months versus conventional immunosuppression in renal allograft recipients
9. Conversion from cyclosporin to azathioprine at 3 months after renal transplantation: Long term results
10. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation
11. A controlled trial of cyclosporin conversion in renal transplantation with conversion to azathioprine and prednisone after 3 months
12. Randomised prospective trial of elective cyclosporin withdrawal from triple therapy at 6 months after cadaveric renal transplantation
13. Long-term, low dose cyclosporin treatment of renal allograft recipients
14. Long-term outcome of a prospective randomised trial of conversion from cyclosporin to azathioprine treatment one year after renal transplantation
15. Long term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomised study from 1 to 6 years after transplantation
16. Elective cyclosporin withdrawal 1 year after renal transplantation
17. Long term results with elective cyclosporin withdrawal at three months after renal transplantation-appropriate for living-related transplants
18. Results of conversion from triple drug to double drug therapy in living related renal transplantation
19. Withdrawal versus continous cyclosporin in kidney transplant recipients of one haplotype matched donors
20. Chronic immunosuppression of the renal transplant recipient
21. Long-term evaluation of two protocols of elective cyclosporin withdrawal in renal transplant recipients
22. Long-term renal allograft survival: Prognostic implication of the timing of acute rejection episodes
23. Features of acute rejection that increase risk of chronic rejection
24. The impact of an acute rejection episode on long term allograft survival (t1/2)